Center for Scientific Review; Notice of Closed Meetings, 38195-38197 [2016-13827]
Download as PDF
<![CDATA[
srobinson on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
• Tell NIDA how you design
scientific experiments in general.
Amount of the Prize; Award
Approving Official. Up to ten monetary
prizes will be awarded. The total prize
award pool is up to $100,000. No
institutional indirect costs are allowed.
The names of the winners and the titles
of their submissions will be posted on
the NIDA Web site. The award
approving official for this Challenge is
the Director of the National Institute on
Drug Abuse.
Payment of the Prize. Prizes awarded
under this Challenge will be paid by
electronic funds transfer and may be
subject to Federal income taxes. The
NIH/NIDA will comply with the
Internal Revenue Service withholding
and reporting requirements, where
applicable.
Basis upon Which the Winner Will Be
Selected. The judging panel will make
recommendations to the award
approving official based upon the
following 5 criteria. Each criterion will
be scored with the maximum of 10
points.
(1) Significance and Unmet Needs (0–
10 points). Are there significant needs
for your product or service? Does the
project address an important problem or
a critical barrier to progress in the field
of drug abuse research? If the aims of
the project are achieved, how will
scientific knowledge, technical
capability, service or clinical practice be
improved?
(2) Innovation (0–10 points). Does the
submission seek to shift current
paradigms by utilizing novel theoretical
concepts, approaches, methodologies,
instrumentation, service or
interventions for drug abuse research? Is
your product novel in a broad sense? Is
a refinement, improvement or new
application of theoretical concepts,
approaches or methodologies
instrumentation or interventions
proposed?
(3) Approach (0–10 points). Are the
overall strategy, methodology, and
analyses well-reasoned and appropriate
to test the proposed idea? Has feedback
from end users been incorporated into
the validity of the idea proposed?
(4) Team expertise (0–10 points). Does
the individual or team demonstrate high
level of ability, perseverance and grit?
(5) Commercialization (0–10 points).
Is there a clear path for the product/
service to reach the market? Are the
product users and purchasers clearly
identified?
Submissions that are responsive and
comply with the entry requirements will
be reviewed by a panel of judges
consisting of federal employees. The
responsive and compliant submissions
VerDate Sep<11>2014
20:48 Jun 10, 2016
Jkt 238001
entries will be scored in accordance
with the judging criteria outlined above.
Final recommendations will be
determined by a vote of the judges based
on score. Scores from each criterion will
be weighted equally, but failure to meet
a minimum standard for any one
criterion might disqualify a submission.
The score for each submission will be
the sum of the scores from each of the
voting judges.
Authority: 15 U.S.C. 3719
Dated: June 7, 2016.
Nora D. Volkow,
Director, National Institute on Drug Abuse,
National Institutes of Health.
[FR Doc. 2016–13936 Filed 6–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA DK15–030
Type 1 Diabetes Pathfinder Award (DP2).
Date: July 14, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Program
Projects (P01).
Date: July 22, 2016.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
38195
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard,
Bethesda, MD 20817, 301–496–9010,
hoffertj@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Minor Endoscopic
Sphincterotomy for Recurrent Acute
Pancreatitis with Pancreas Divisum.
Date: July 25, 2016.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Psychological and
Behavioral Mechanisms in Bariatric Surgery
(R01).
Date: July 26, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 6, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13828 Filed 6–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
E:\FR\FM\13JNN1.SGM
13JNN1
38196
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
srobinson on DSK5SPTVN1PROD with NOTICES
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; CVRS
Member Conflicts and Continuous
Submissions.
Date: June 28, 2016.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Olga A. Tjurmina, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301) 451–
1375, ot3d@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Developmental and Motor
Disability.
Date: July 6, 2016.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–500–
5829, sechu@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group;
Behavioral and Social Science Approaches to
Preventing HIV/AIDS Study Section.
Date: July 7–8, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Innovative
Strategies to Reduce HIV Incidence—iKnow
Projects.
Date: July 7, 2016.
VerDate Sep<11>2014
20:48 Jun 10, 2016
Jkt 238001
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Fairmont Washington DC, 2401 M
Street NW., Washington, DC 20008.
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Healthcare Delivery and
Methodologies.
Date: July 7, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jessica Bellinger, Ph.D.,
Center for Scientific of Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3158, Bethesda, MD 20892,
bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Radiation Therapy and Biology.
Date: July 12–13, 2016.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Alcohol, Neurotoxicology and
Drugs.
Date: July 13–14, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, selmanom@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Digestive Sciences.
Date: July 13, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Martha Garcia, Ph.D.,
Scientific Reviewer Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186,
MSC 7818, Bethesda, MD 20892, 301–435–
1243, garciamc@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Microbial Pathogenesis.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Date: July 13, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 240–519–
7808, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
16–005: Environmental Influences on Child
Health Outcomes (ECHO) Data Analysis
Center (DAC).
Date: July 13, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Heidi B. Friedman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A,
MSC 7770, Bethesda, MD 20892, 301–379–
5632, hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Pain and Chemosensory
Mechanisms.
Date: July 13–14, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Novel
Genomic Technology Development.
Date: July 13, 2016.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Dominique Lorang-Leins,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7766, Bethesda, MD 20892,
301.326.9721, Lorangd@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Therapeutics.
Date: July 13, 2016.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Denise R. Shaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\13JNN1.SGM
13JNN1
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biomarkers, Bioassays, Animal
Models and Related Technologies for
Neurologic Disorders.
Date: July 13, 2016.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Yvonne Bennett, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5199,
MSC 7846, Bethesda, MD 20892, 301–379–
3793, bennetty@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 7, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13827 Filed 6–10–16; 8:45 am]
additional two-year period on April 14,
2016.
It is determined that the National
Cancer Institute Clinical Trials and
Translational Research Advisory
Committee is in the public interest in
connection with the performance of
duties imposed on the National Cancer
Institute and National Institutes of
Health by law, and that these duties can
best be performed through the advice
and counsel of this group.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
Dated: June 7, 2016.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13829 Filed 6–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
BILLING CODE 4140–01–P
Coast Guard
[Docket No. USCG–2016–0372]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Certificates of Alternative Compliance,
First Coast Guard District
National Institutes of Health
Coast Guard, DHS.
Notice.
AGENCY:
National Cancer Institute; Notice of
Charter Renewal
ACTION:
The Coast Guard announces
that the First Coast Guard District’s
Prevention Department has issued
certificates of alternative compliance
with the International Regulations for
Preventing Collisions at Sea (72
COLREGS), to vessels of special
construction or purpose that cannot
SUMMARY:
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the National
Cancer Institute Clinical Trials and
Translational Research Advisory
Committee was renewed for an
38197
fully comply with the light, shape, and
sound signal provisions of 72 COLREGS
without interfering with their special
function. This notice promotes the Coast
Guard’s maritime safety and
stewardship missions.
FOR FURTHER INFORMATION CONTACT: For
information about this document call or
email Mr. Kevin Miller, First Coast
Guard District’s Towing Vessel and
Barge Safety Specialist at (617) 223–
8272 or [Kevin.L.Miller2@uscg.mil].
SUPPLEMENTARY INFORMATION:
Discussion
The United States is signatory to the
International Maritime Organization’s
International Regulations for Preventing
Collisions at Sea, 1972, as amended.
The special construction or purpose of
some vessels makes them unable to
comply with the light, shape, and sound
signal provisions of 72 COLREGS.
Under statutory law 1 and Coast Guard
regulation,2 a vessel may instead meet
alternative requirements and the
vessel’s owner, builder, operator, or
agent may apply for a certificate of
alternative compliance (COAC). The
Chief of the Inspections and
Investigations Branch in each Coast
Guard District office determines
whether the vessel for which the COAC
is sought complies as closely as possible
with 72 COLREGS, and decides whether
to issue the COAC. Once issued, a
COAC remains valid until information
supplied in the application for the
COAC, or the terms of the COAC,
become inapplicable to the vessel.
Under the governing statute 3 and
regulation,4 the Coast Guard must
publish notice of each COAC issued by
the District office.
The First Coast Guard District issued
COACs to the following vessels from
January 2016 to May 2016:
Vessel name
Details
2016 ........................
JACK T MORAN ....................................
2016 ........................
GRACIE M REINAUER .........................
2016 ........................
srobinson on DSK5SPTVN1PROD with NOTICES
Year
COOPER MORAN .................................
This certificate authorized the placement of the vessel’s sidelights in a position
13′ 5.25″ from the vessel’s side, mounted to the top of the pilot house. Additionally, this certificate authorized the placement of the vessel’s stern light
and towing lights in a position 3′ 5.75″ aft of Frame 20, mounted on the top
of the pilot house.
This certificate authorized the placement of the vessel’s sidelights in a position
7′ 1.75″ from the vessel’s side, mounted to the deckhouse overhead.
This certificate authorized the placement of the vessel’s sidelights in a position
13′ 5.25″ from the vessel’s side, mounted to the top of the pilot house. Additionally, this certificate authorized the placement of the vessel’s stern light
and towing lights in a position 3′ 5.75″ aft of Frame 20, mounted on the top
of the pilot house.
1 33
2 33
U.S.C. 1605.
CFR 81.3.
VerDate Sep<11>2014
20:48 Jun 10, 2016
3 33
4 33
Jkt 238001
PO 00000
U.S.C. 1605(c).
CFR 81.18.
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Pages 38195-38197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13827]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
[[Page 38196]]
hereby given of the following meetings. The meetings will be closed to
the public in accordance with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; CVRS Member Conflicts and Continuous Submissions.
Date: June 28, 2016.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Olga A. Tjurmina, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138, MSC 7814, Bethesda, MD
20892, (301) 451-1375, ot3d@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Developmental and Motor Disability.
Date: July 6, 2016.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Serena Chu, Ph.D., Scientific Review Officer,
BBBP IRG, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD
20892, 301-500-5829, sechu@csr.nih.gov.
Name of Committee: AIDS and Related Research Integrated Review
Group; Behavioral and Social Science Approaches to Preventing HIV/
AIDS Study Section.
Date: July 7-8, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street NW.,
Washington, DC 20037.
Contact Person: Jose H. Guerrier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892, 301-435-1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Innovative Strategies to Reduce HIV Incidence--iKnow
Projects.
Date: July 7, 2016.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Fairmont Washington DC, 2401 M Street NW., Washington, DC
20008.
Contact Person: Jose H. Guerrier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD
20892, 301-435-1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Healthcare Delivery and Methodologies.
Date: July 7, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Jessica Bellinger, Ph.D., Center for Scientific
of Review, National Institutes of Health, 6701 Rockledge Drive, Room
3158, Bethesda, MD 20892, bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Radiation Therapy and Biology.
Date: July 12-13, 2016.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bo Hong, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301-996-
6208, hongb@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Alcohol, Neurotoxicology and Drugs.
Date: July 13-14, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD
20892, 301-435-1119, selmanom@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Digestive Sciences.
Date: July 13, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: Martha Garcia, Ph.D., Scientific Reviewer
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD
20892, 301-435-1243, garciamc@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Microbial Pathogenesis.
Date: July 13, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Richard G. Kostriken, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, 240-519-7808, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-16-005: Environmental Influences on Child Health
Outcomes (ECHO) Data Analysis Center (DAC).
Date: July 13, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Heidi B. Friedman, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A, MSC 7770, Bethesda, MD
20892, 301-379-5632, hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Pain and Chemosensory Mechanisms.
Date: July 13-14, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Novel Genomic Technology Development.
Date: July 13, 2016.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dominique Lorang-Leins, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108, MSC 7766, Bethesda, MD
20892, 301.326.9721, Lorangd@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Therapeutics.
Date: July 13, 2016.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Denise R. Shaw, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
[[Page 38197]]
Health, 6701 Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD
20892, 301-435-0198, shawdeni@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Biomarkers, Bioassays, Animal Models and
Related Technologies for Neurologic Disorders.
Date: July 13, 2016.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yvonne Bennett, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5199, MSC 7846, Bethesda, MD
20892, 301-379-3793, bennetty@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 7, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-13827 Filed 6-10-16; 8:45 am]
BILLING CODE 4140-01-P
